ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for monitor Customisable watchlists with full streaming quotes from leading exchanges, such as LSE, NASDAQ, NYSE, AMEX, Bovespa, BIT and more.

DMTKW DermTech Inc (PK)

0.0013
0.00 (0.00%)
14 Jun 2024 - Closed
Delayed by 15 minutes
Name Symbol Market Type
DermTech Inc (PK) USOTC:DMTKW OTCMarkets Equity Warrant
  Price Change % Change Price Bid Price Offer Price High Price Low Price Open Price Traded Last Trade
  0.00 0.00% 0.0013 0.0006 0.0039 0.00 21:00:05

Initial Statement of Beneficial Ownership (3)

30/03/2020 9:07pm

Edgar (US Regulatory)


FORM 3
        
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

OMB APPROVAL
OMB Number: 3235-0104
Estimated average burden
hours per response...
0.5
                      
Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940
                      

1. Name and Address of Reporting Person *

Ibarra Claudia
2. Date of Event Requiring Statement (MM/DD/YYYY)
3/18/2020 

3. Issuer Name and Ticker or Trading Symbol

DermTech, Inc. [DMTK]
(Last)        (First)        (Middle)

C/O DERMTECH, INC., 110999 N. TORREY PINES RD. SUITE 100
4. Relationship of Reporting Person(s) to Issuer (Check all applicable)

_____ Director                          _____ 10% Owner
___X___ Officer (give title below)        _____ Other (specify below)
Chief Operating Officer /
(Street)

SAN DIEGO, CA 92037      

(City)              (State)              (Zip)
5. If Amendment, Date Original Filed(MM/DD/YYYY)
 

6. Individual or Joint/Group Filing(Check Applicable Line)

_X_ Form filed by One Reporting Person
___ Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1.Title of Security
(Instr. 4)
2. Amount of Securities Beneficially Owned
(Instr. 4)
3. Ownership Form: Direct (D) or Indirect (I)
(Instr. 5)
4. Nature of Indirect Beneficial Ownership
(Instr. 5)
Common Stock 110625 (1)D  

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivate Security
(Instr. 4)
2. Date Exercisable and Expiration Date
(MM/DD/YYYY)
3. Title and Amount of Securities Underlying Derivative Security
(Instr. 4)
4. Conversion or Exercise Price of Derivative Security5. Ownership Form of Derivative Security: Direct (D) or Indirect (I)
(Instr. 5)
6. Nature of Indirect Beneficial Ownership
(Instr. 5)
Date ExercisableExpiration DateTitleAmount or Number of Shares

Explanation of Responses:
(1) The securities are in the form of restricted stock units issued pursuant to the issuer's Amended and Restated 2010 Stock Plan. Each restricted stock unit represents a contingent right to receive one share of issuer common stock. Subject to the reporting person's continued service, nine forty-eighths (9/48) of the restricted stock units shall vest on September 7, 2020 and the remaining thirty-nine forty-eighths (39/48) shall vest in thirteen (13) equal installments of three forty-eighths (3/48) on the seventh day of each third month following September 7, 2020 until the final vesting date on December 7, 2023.

Remarks:
Exhibit List Exhibit 24 - Power of Attorney of Claudia Ibarra

Reporting Owners
Reporting Owner Name / Address
Relationships
Director10% OwnerOfficerOther
Ibarra Claudia
C/O DERMTECH, INC.
110999 N. TORREY PINES RD. SUITE 100
SAN DIEGO, CA 92037


Chief Operating Officer

Signatures
/s/ Jason S. Miller, attorney-in-fact3/30/2020
**Signature of Reporting PersonDate

1 Year DermTech (PK) Chart

1 Year DermTech (PK) Chart

1 Month DermTech (PK) Chart

1 Month DermTech (PK) Chart

Your Recent History

Delayed Upgrade Clock